metabolic determinants cancer cell sensitivity glucose limitation biguanides 
concentrations highly consumed nutrients particularly glucose generally lower tumours normal tissues12 cancer cells must adapt metabolism tumour microenvironment abetter understanding adaptations might reveal cancer cell liabilities can exploited therapeutic benefit developed continuous-flow culture apparatus nutrostat maintaining proliferating cells low-nutrient media long periods time used undertake competitive proliferation assays pooled collection barcoded cancer cell lines cultured low-glucose conditions sensitivity low glucose varies amongst cell lines rna interference rnai screen pinpointed mitochondrial oxidative phosphorylation oxphos major pathway required optimal proliferation low glucose found cell lines sensitive low glucose defective oxphos upregulation normally caused glucose limitation result either mitochondrial dna mtdna mutations complex genes impaired glucose utilization defects predict sensitivity biguanides antidiabetic drugs inhibit oxphos34 cancer cells grown low glucose tumour xenografts notably biguanide sensitivity cancer cells mtdna mutations reversed ectopic expression yeast ndi1 ubiquinone oxidoreductase allows bypass complex function5 thus conclude mtdna mutations impaired glucose utilization potential biomarkers identifying tumours increased sensitivity oxphos inhibitors 
